Cosmo Pharmaceuticals NV
F:C43
Cosmo Pharmaceuticals NV
F:C43
Price:
85.2
EUR
-3.07%
Market Closed
Market Cap:
€1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cosmo Pharmaceuticals NV
F:C43
|
IE |
|
P
|
Packaging Corp of America
XMUN:PKA
|
US |
|
Z
|
Zurich Insurance Group AG
DUS:ZFIN
|
CH |
|
C
|
Corcept Therapeutics Inc
F:HTD
|
US |
Wall St Price Targets
C43 Price Targets Summary
Cosmo Pharmaceuticals NV
Cosmo Pharmaceuticals NV
Wall Street analysts forecast C43 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for C43 is 108.71 EUR with a low forecast of 83.5 EUR and a high forecast of 137.52 EUR.
Lowest Forecast
Price Target
83.5
EUR
2% Downside
Average Forecast
Price Target
108.71
EUR
28% Upside
Highest Forecast
Price Target
137.52
EUR
61% Upside
Cosmo Pharmaceuticals NV Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C43's stock price target?
Price Target
108.71
EUR
108.71
EUR
According to Wall Street analysts, the average 1-year price target for C43 is 108.71 EUR with a low forecast of 83.5 EUR and a high forecast of 137.52 EUR.
What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
37%
37%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 37%.
